Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
InterAACT: Cisplatin+5FU vs Carboplatin+Paclitaxel in Advanced Anal Cancer
NCT02051868Phase 2Unknown
- Sponsor
- Royal Marsden NHS Foundation Trust
- Start
- Dec 2013
- Primary completion
- Aug 2017
- Modality
- DNA Intercalators/Alkylators, Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 3
01
Overview
A Phase 2 trial of carboplatin, Paclitaxel Micelles for Injection in anal squamous cell carcinoma (SCCA), sponsored by Royal Marsden NHS Foundation Trust. Status: unknown.
02
Drugs
carboplatinPaclitaxel Micelles for Injection
03
Conditions
anal squamous cell carcinoma (SCCA)
Beyond the preview
Go deeper on NCT02051868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02051868.